Documents and Emails Now Prove the FDA and CDC Concealed Data on COVID-19 Cases Actually Being Worse in Those Vaccinated
In 2021, the occurrence of COVID-19 cases in vaccinated seniors saw a notable surge, a revelation drawn from recently unearthed data amassed by U.S. health agencies, yet kept from the public eye.
U.S. military contracted Humetrix Cloud Services to undertake an analysis of vaccine data. As discussions around the necessity of COVID-19 vaccine boosters in 2021 gained traction due to diminishing vaccine efficacy, Humetrix conducted a fresh analysis.
The findings unveiled by Humetrix researchers indicated that the proportion of total COVID-19 cases among senior citizens increasingly consisted of individuals who had been vaccinated, as per the newly disclosed documents by ICANDECIDE.ORG.
For the week concluding on July 31, 2021, post-vaccination COVID-19 cases accounted for a significant 73 percent of cases in individuals aged 65 and above. Notably, at that time, 80 percent of seniors had received their full vaccination regimen.
The researchers noted higher breakthrough infection rates among early vaccine recipients, estimating that those vaccinated five to six months earlier experienced twice the rate of breakthrough cases compared to individuals vaccinated three to four months prior.
The data pinpointed the onset of breakthrough cases as early as January 2021.
Furthermore, the data revealed that the protection against hospitalization was diminishing, a troubling discovery in its own right.
Related: Are Covid Lockdowns Coming Back?
In the same week ending on July 31, 2021, fully vaccinated seniors constituted 63 percent of COVID-19 hospitalizations, as per the disclosed documents. This pattern of reduced protection among early vaccine recipients was consistently observed.
The researchers computed that vaccine effectiveness (VE) against infection had dwindled to a mere 33 percent, while protection against hospitalization had dropped to 57 percent.
Intriguingly, the study unveiled that seniors who had previously contracted and recovered from COVID-19 were more likely to avoid hospitalization. Risk factors included underlying health conditions such as obesity and belonging to the oldest age group, individuals aged 85 and older.
This comprehensive analysis encompassed 20 million Medicare beneficiaries, including 5.6 million seniors who had received the primary series of a COVID-19 vaccine.
Dr. Bettina Experton, President and CEO of Humetrix, communicated these concerning VE findings in an email to high-ranking officials at the U.S. Food and Drug Administration (FDA) on September 15, 2021.
Humetrix also disclosed this data to the U.S. Centers for Disease Control and Prevention (CDC) in August 2021.
FDA official Dr. Peter Marks expressed his surprise, stating, “It would have been preferable to be aware of this military study earlier. Additionally, it would have been beneficial for the CDC to share this data.”
Dr. Janet Woodcock, then Acting Commissioner of the FDA, echoed these sentiments, declaring, “In my opinion, this is more disconcerting than the other data we possess.”
The Informed Consent Action Network, a nonprofit dedicated to promoting transparency in medical matters, obtained these presentations and emails through the Freedom of Information Act (FOIA).
Del Bigtree, the network’s founder, conveyed his concerns: “It is difficult to interpret this as anything other than a failure of our health authorities to evaluate, disseminate, publicize, and act upon valuable real-world data amidst what is termed a pandemic. Without FOIA, the public would likely remain unaware of these shortcomings, enabling their recurrence.”
Of course, both the FDA and CDC declined to provide comments to ICANDECIDE.ORG.
In a separate email acquired through FOIA, Dr. Francis Collins, then Director of the U.S. National Institutes of Health, highlighted the study’s findings as “compelling evidence that VE is declining 5–6 months post-vaccination for those over 65, both in terms of infection and hospitalization.” He also noted a trend toward diminishing VE even for individuals 3–4 months post-vaccination.
The CDC, FDA, and National Institutes of Health withheld this data from the public while deliberating whether to endorse covid vaccine boosters.
On August 30, 2021, the CDC convened with its vaccine advisers to discuss emerging data on waning vaccine effectiveness, though the military study was conspicuously absent from the discussion.
A similar meeting was held by the FDA on September 17, 2021, with CDC participation, where the Humetrix analysis remained undisclosed.
Throughout the pandemic, both agencies vigorously advocated for COVID-19 vaccines, emphasizing their efficacy in preventing severe disease, despite their own data suggesting otherwise.
The CDC did present data from its COVID-NET system, indicating declining effectiveness against COVID-19-associated hospitalization among the elderly since the emergence of the Delta variant. However, this data still indicated an 80 percent effectiveness rate.
The presentation also included data from external researchers and Israel, estimating Delta-era protection against infection ranging from 39 percent to 84 percent and effectiveness against hospitalization ranging from 75 to 95 percent.
Ultimately, the FDA authorized a Pfizer booster for many Americans, with the CDC recommending it for most. Subsequently, both agencies expanded booster eligibility and recommendations to virtually all Americans aged 5 and above, offering Moderna’s shot as an alternative. Authorities have since replaced the original shots due to their limited durability and are preparing to introduce a new series of shots this fall.
We’ll have to see just how “effective” the shots really are. Want to be the guinea pig? Let us know how fed up YOU are with the FDA and CDC in the comments below.